None listed
Conditions
Interventions
None listed
Sponsors
Dr Shreya Sharma
Eligibility
Inclusion criteria
Inclusion criteria: Subjects of age group between 18 to 35 years who are willing to take part in the study Subjects in second trimester of pregnancy (13 to 20 weeks) with Haemoglobin level greater than 10.9 gm/dl. Subjects with normal singleton intrauterine pregnancy. Informed and written consent
Exclusion criteria
Exclusion criteria: Subjects with already and newly diagnosed case of PIH (BP greater than 140/90 mm of Hg on 2 separate occasions 4 hr apart) Subjects with already and newly diagnosed case of gestational diabetes (RBS greater than 140mg/dl) Subjects with diagnosed case of any heart disease Subjects with diagnosed case of any liver disease Subjects with diagnosed case of any coagulopathy Any congenital abnormality found in USG
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Between group difference of approximate 10% reduction in incidence of anemia in test group in late second trimester of pregnancy.Timepoint: 0th and 60th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Approximate 25% reduction in incidence of symptoms associated with intake of Iron Folic Acid Tabs. Approximate 25% reduction in participants with non-adherence of Iron Folic Acid tabs Timepoint: 0th and 60th day | — |
Countries
India
Contacts
Public ContactDr Shreya Sharma
Shri Dhanwantry ayurvedic college and hospital
Outcome results
None listed